The future of cell and gene therapies in the UK is a policy programme designed to identify practical and
actionable steps to address the current skills shortages seen in Cell and Gene Therapy (CGT) and wider life sciences sector. The findings and recommendations are aimed at key leaders from government, industry and academia.
The programme included a series of three roundtables conducted throughout 2022/23, chaired by Dr Anji Miller Lead for Gene Therapy Innovation Hubs & Senior Business Manager at LifeArc.
The roundtables were attended by cell and gene therapy leaders and experts throughout the UK, including academics, researchers, and professionals from the public and private sectors.
This report covers the key insights, opinions and recommendations that emerged from each discussion. It is not an exhaustive account of issues relating to cell and gene therapies and the wider life sciences sector, but rather a summary of key issues raised by a group of experts and stakeholders.
Sponsorship for this programme has been provided by LifeArc, the University of Birmingham and Birmingham Health Partners.